Trump Expands Pharmaceutical Pricing Agreement Amid Healthcare Stock Rally

Donald Trump has extended his drug pricing agreement to include 26 pharmaceutical companies. Meanwhile, UBS analysts suggest that healthcare stocks maintain further potential for growth.